Business Description
P3 Health Partners Inc
NAICS : 621999
SIC : 9431
ISIN : US7444131053
Share Class Description:
PIII: Class ADescription
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.5 | |||||
| Equity-to-Asset | 0.19 | |||||
| Debt-to-Equity | 0.88 | |||||
| Debt-to-EBITDA | -1.94 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.29 | |||||
| Beneish M-Score | -2.32 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -15.8 | |||||
| 3-Year EBITDA Growth Rate | 12.6 | |||||
| 3-Year EPS without NRI Growth Rate | -11 | |||||
| 3-Year FCF Growth Rate | 13.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | 18.01 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 17.33 | |||||
| 9-Day RSI | 25.75 | |||||
| 14-Day RSI | 32.46 | |||||
| 6-1 Month Momentum % | -40.91 | |||||
| 12-1 Month Momentum % | -56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.69 | |||||
| Quick Ratio | 0.69 | |||||
| Cash Ratio | 0.21 | |||||
| Days Sales Outstanding | 36.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.6 | |||||
| Shareholder Yield % | -76.68 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -12.35 | |||||
| Net Margin % | -4.95 | |||||
| FCF Margin % | -3.84 | |||||
| ROE % | -68.47 | |||||
| ROA % | -7.87 | |||||
| ROIC % | -25.03 | |||||
| ROC (Joel Greenblatt) % | -1871.8 | |||||
| ROCE % | -27.78 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.06 | |||||
| PB Ratio | 0.46 | |||||
| EV-to-EBIT | -0.96 | |||||
| EV-to-EBITDA | -2.06 | |||||
| EV-to-Forward-EBITDA | -4.06 | |||||
| EV-to-Revenue | 0.11 | |||||
| EV-to-Forward-Revenue | 0.15 | |||||
| EV-to-FCF | -2.87 | |||||
| Earnings Yield (Greenblatt) % | -104.17 | |||||
| FCF Yield % | -70.94 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers